Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD Read more
Highlighting Advantages of the Whole-industry-chain Layout, Starting the New Journey of Internationalization of Pharmaceuticals Read more
Xeris Doses First Patient in Phase 2 Trial Evaluating Its Ready-to-Use Glucagon to Address Exercise-Induced Hypoglycemia Read more
Iktos Announces Collaboration with Merck for Use of Iktos AI Technology across Three Drug Discovery Projects Read more
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company Read more
EC approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors Read more